CEVA SANTE ANIMALE S A has a total of 11 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Brazil, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are GUANGZHOU XIANGXUE PHARMACEUTICAL CO LTD, BIOMEDICAL RES MODELS INC and PENN MARC S.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | China | 2 | |
#4 | Australia | 1 | |
#5 | United Kingdom | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Surface technology and coating | |
#6 | Environmental technology | |
#7 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Seele Jana | 4 |
#2 | Baums Christoph | 4 |
#3 | Valentin-Weigand Peter | 4 |
#4 | Rosenberger Sandra Cloud | 2 |
#5 | Dorsey Kristi Mae | 2 |
#6 | Rosenberger John Knox | 2 |
#7 | Kaiser Christian | 1 |
#8 | Yannick Gardin | 1 |
#9 | Wilke Jürgen | 1 |
#10 | Guimberteau Florence | 1 |
Publication | Filing date | Title |
---|---|---|
CN102170904A | Composition comprising chitosan for ocular administration of vaccine(s) to avians | |
BRPI0910195A2 | astrovirus serotype isolated, isolated nucleotide sequence, construct containing an isolated nucleotide sequence, vector, polypeptide sequence, vaccine, isolated antiserum, isolated antibody, method for protection or vaccination of birds, diagnostic test method, container for vaccination of birds, bird vaccination kit, diagnostic kit, method for propagating astrovirus, cell line for the spread of astrovirus isolate |